Identification of a novel candidate splice site mutation (0874 + 1G > A) in a type 3 von Willebrand disease patient
Gadisseur, A.P.; Vrelust, I.; Vangenechten, I.; Schneppenheim, R.; Van der Planken, M.
Thrombosis and Haemostasis 98(2): 464-466
2007
ISSN/ISBN: 0340-6245 PMID: 17721632 Document Number: 607301
Document emailed within 1 workday
Related Documents
Hilbert, L.; Federici, A.B.; Baronciani, L.; Dallagiovanna, S.; Mazurier, C. 2004: A new candidate mutation, G1629R, in a patient with type 2A von Willebrand's disease: basic mechanisms and clinical implications Haematologica 89(9): 1128-1133Paradisi, M.; Massé, M.; Martinez-Mir, A.; Lam, H.; Pedicelli, C.; Christiano, A.M. 2005: Identification of a novel splice site mutation in the human hairless gene underlying atrichia with papular lesions European Journal of Dermatology: Ejd 15(5): 332-338
Tatewaki, H.; Iida, H.; Nakahara, M.; Tsuda, H.; Kinoshita, S.; Kanaji, T.; Yoshida, N.; Miyazaki, S.; Hamasaki, N. 1999: A novel splice acceptor site mutation which produces multiple splicing abnormalities resulting in protein S deficiency type i Thrombosis and Haemostasis 82(1): 65-71
Inbal, A.; Kornbrot, N.; Harrison, P.; Randi, A.M.; Sadler, J.E. 1993: Effect of type IIB von Willebrand disease mutation Arg(545)Cys on platelet glycoprotein Ib binding--studies with recombinant von Willebrand factor Thrombosis and Haemostasis 70(6): 1058-1062
Lethagen, S.; Isaksson, C.; Schaedel, C.; Holmberg, L. 2002: Von Willebrand's disease caused by compound heterozygosity for a substitution mutation (T1156M) in the D3 domain of the von Willebrand factor and a stop mutation (Q2470X) Thrombosis and Haemostasis 88(3): 421-426
Hedley, M.L.; Forman, J.; Tucker, P.W. 1989: Mutation of 3' splice sites in two different class I genes results in different usage of cryptic splice sites Journal of Immunology 143(3): 1018-1025
Mazurier, C.; Meyer, D. 1996: Factor VIII binding assay of von Willebrand factor and the diagnosis of type 2N von Willebrand disease--results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH Thrombosis and Haemostasis 76(2): 270-274
Piao, Y.C.; Lavergne, J.M.; Boyer-Neumann, C.; Schandelong, A.; Alessi, M.C.; Meyer, D. 1993: Arg578Gln mutations in the von Willebrand factor gene in three unrelated cases of type IIB von Willebrand disease Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 4(5): 787-789
Poort, S.R.; Briët, E.; Bertina, R.M.; Reitsma, P.H. 1990: Two mutations of the factor IX gene including a donor splice consensus deletion and a point mutation in a Dutch patient with severe hemophilia B Thrombosis and Haemostasis 64(3): 379-384
Rastegar-Lari, G.; Ajzenberg, N.; Ribba, A.S.; Vereycken-Holler, V.; Legendre, P.; Villoutreix, B.; Meyer, D.; Baruch, D. 2001: Defect of heparin binding in plasma and recombinant von Willebrand factor with type 2 von Willebrand disease mutations Thrombosis and Haemostasis 86(6): 1459-1465
Van Vliet, H.H.D.M.; Kappers-Klunne, M.C.; Leebeek, F.W.G.; Michiels, J.J. 2008: PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2 Thrombosis and Haemostasis 100(3): 462-468
Germain, D.P.; Kaneski, C.R.; Brady, R.O. 2001: Mutation analysis of the acid beta-glucosidase gene in a patient with type 3 Gaucher disease and neutralizing antibody to alglucerase Mutation Research 483(1-2): 89-94
Shibata, M.; Shima, M.; Fujimura, Y.; Takahashi, Y.; Nakai, H.; Sakurai, Y.; Asatani, M.; Nomura, A.; Take, H.; Giddings, J.C.; Yoshioka, A. 1999: Identification of the binding site for an alloantibody to von Willebrand factor which inhibits binding to glycoprotein Ib within the amino-terminal region flanking the A1 domain Thrombosis and Haemostasis 81(5): 793-798
Habart, D. 2003: Von Willebrand disease type 2N (Normandy) Vnitrni Lekarstvi 49(4): 253-255
Nordmann, A. 1998: Mild von type i von Willebrand disease Praxis 87(21): 747-748
Miller, J.L. 1996: Platelet-type von Willebrand disease Thrombosis and Haemostasis 75(6): 865-869
Zaboĭkin, M.M.; Moiseev, V.L.; Shapot, V.S.; Likhtenshteĭn, A.V. 1988: Identification of the stable DNA-matrix complex (type II) as a site of replication fork Molekuliarnaia Biologiia 22(4): 1119-1127
Xu, B.; Pang, T.; Yao, C.-q.; Zhang, L.-y.; Zheng, H.; Jiang, W.-y.; Li, H.-y. 2012: Identification of a novel pathogenic mutation in MATP gene with oculocutaneous albinism type IV from a consanguineous marriage family Zhonghua Yi Xue Za Zhi 92(4): 254-258
Inocêncio, G.; Braga, A.; Azevedo, S.; Buchner, G. 2013: Management of von Willebrand disease type 3 during pregnancy - 2 cases reports European Review for Medical and Pharmacological Sciences 17(21): 2857-2859
Ogawa, H.; Kurashige, J.; Ohta, Y.; Suzuki, N. 1981: Anesthesia for a patient with von Willebrand's disease Masui. Japanese Journal of Anesthesiology 30(5): 486-492